RebrAIn Secures Second FDA Clearance for Enhancing Targeting in Neurosurgery
RebrAIn, a leader in precision neuro-surgery platforms, has secured its second FDA 510(k) clearance for its OptimMRI software. The latest version includes a machine learning model designed to aid in…
Median Technologies’ eyonis™ LCS Lung Cancer Diagnostic Hits All Study Endpoints
Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible) announced that its AI-powered diagnostic tool, eyonis™ LCS, met the primary and all secondary endpoints in the REALITY study, the first of two…
Kaneka Completes New Medical Device Plant in Hokkaido
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO: 4118) has opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido, marking its seventh domestic business location and…
Alnylam Shares HELIOS-B Phase 3 Results on Vutrisiran for ATTR Amyloidosis at ESC Congress
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic for the treatment of…
Novotech Reaccredited as Employer of Choice for Gender Equality
Novotech, a global full-service clinical Contract Research Organization (CRO), is pleased to announce its renewal as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Equality (EOCGE) for…
Allurion Publishes Data Showing Continued Weight Loss After One Year on Its Program
Allurion Technologies, Inc. (NYSE: ALUR) has announced new study results showing an average weight reduction of 10.5% at four months, improving to 13.7% at one year with the Allurion Program.…
Azitra Doses First Patient in Phase 1b ATR-12 Trial for Netherton Syndrome
Azitra, Inc. (NYSE American: AZTR), a leader in precision dermatology, has begun dosing the first patient in its Phase 1b trial of ATR-12 for Netherton syndrome. The trial will involve…
BostonGene Highlights AI Multiomics Platform and Immune Profiling Advances at World Biomarkers Summit
BostonGene, a leader in AI-driven molecular and immune profiling, will showcase its advanced technologies at the 14th World Clinical Biomarkers & CDx Summit 2024, held from September 3 – 6…
SDC Capture Transforms Clinical Trials with New BYOD ePRO Solution
Statistics & Data Corporation (SDC), a leader in life sciences biometrics and technology solutions, has introduced its innovative Bring Your Own Device (BYOD) electronic Patient Reported Outcomes (ePRO) solution. This…
Modivcare and ACC Launch Caring Hearts Initiative in New Jersey
Modivcare Inc. (Nasdaq: MODV), a technology-driven healthcare services company, is teaming up with the American College of Cardiology (ACC) to launch the Caring Hearts Initiative in Camden County, New Jersey.…
Repare Therapeutics Shifts Focus to Clinical Portfolio
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, announced a strategic shift to prioritize the development of its clinical-stage oncology programs. The company will concentrate on advancing its…
Significant Need for Innovative Endovascular Devices to Treat BTA Disease in CLI Patients
Research by THE SAGE GROUP analyzes the prevalence, characteristics, comorbidities, and outcomes of below-the-ankle (BTA) disease, while also exploring the challenges of endovascular revascularization. BTA (below-the-ankle) disease involves atherosclerotic stenoses…